Related references
Note: Only part of the references are listed.SCIP: solving constraint integer programs
Tobias Achterberg
MATHEMATICAL PROGRAMMING COMPUTATION (2009)
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows lowtoxicity and robust immunogenicity
Gemma G. Kenter et al.
CLINICAL CANCER RESEARCH (2008)
A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer
Kimberly A. Chianese-Bullock et al.
JOURNAL OF IMMUNOTHERAPY (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Immunologic and clinical outcomes of a Randomized phase II trial of two multipeptide Vaccines for melanoma in the adjuvant setting
Craig L. Slingluff et al.
CLINICAL CANCER RESEARCH (2007)
Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method
Morten Nielsen et al.
BMC BIOINFORMATICS (2007)
Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults
Michel Moutschen et al.
VACCINE (2007)
More than one reason to rethink the use of peptides in vaccine design
Anthony W. Purcell et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Coping with viral diversity in HIV vaccine design
David C. Nickle et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
Virus-epitope vaccine design: Informatic matching the HLA-I polymorphism to the virus genome
Tal Vider-Shalit et al.
MOLECULAR IMMUNOLOGY (2007)
Determination of a HLA II promiscuous peptide cocktail as potential vaccine against EBV latency II malignancies
Stephane Depil et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers
Paul A. Goepfert et al.
VACCINE (2007)
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
Will Fischer et al.
NATURE MEDICINE (2007)
SVMHC:: a server for prediction of MHC-binding peptides
Pierre Donnes et al.
NUCLEIC ACIDS RESEARCH (2006)
A community resource benchmarking predictions of peptide binding to MHC-I molecules
Bjoern Peters et al.
PLOS COMPUTATIONAL BIOLOGY (2006)
Phase I trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer
J Nemunaitis et al.
MOLECULAR THERAPY (2006)
Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers
Maryline Mancini-Bourgine et al.
VACCINE (2006)
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma
N Yajima et al.
CLINICAL CANCER RESEARCH (2005)
Integrated modeling of the major events in the MHC class I antigen processing pathway
P Dönnes et al.
PROTEIN SCIENCE (2005)
Automated generation and evaluation of specific MHC binding predictive tools:: ARB matrix applications
HH Bui et al.
IMMUNOGENETICS (2005)
Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method
B Peters et al.
BMC BIOINFORMATICS (2005)
Solving and analyzing side-chain positioning problems using linear and integer programming
CL Kingsford et al.
BIOINFORMATICS (2005)
HIV vaccine development by computer assisted design: the GAIA vaccine
AS De Groot et al.
VACCINE (2005)
The Los Alamos hepatitis C sequence database
C Kuiken et al.
BIOINFORMATICS (2005)
The Tubingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy
H Singh-Jasuja et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
MUSCLE: multiple sequence alignment with high accuracy and high throughput
RC Edgar
NUCLEIC ACIDS RESEARCH (2004)
Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach
M Nielsen et al.
BIOINFORMATICS (2004)
Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach
S Buus et al.
TISSUE ANTIGENS (2003)
Epitope-based vaccines: an update on epitope identification, vaccine design and delivery
A Sette et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Reliable prediction of T-cell epitopes using neural networks with novel sequence representations
M Nielsen et al.
PROTEIN SCIENCE (2003)
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells
CL Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
